These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2972859)

  • 1. Nephritogenicity of proteoglycans. II. A model of immune complex nephritis.
    Makino H; Lelongt B; Kanwar YS
    Kidney Int; 1988 Aug; 34(2):195-208. PubMed ID: 2972859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephritogenicity of proteoglycans. III. Mechanism of immune deposit formation.
    Makino H; Lelongt B; Kanwar YS
    Kidney Int; 1988 Aug; 34(2):209-19. PubMed ID: 2972860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane--I.
    Makino H; Gibbons JT; Reddy MK; Kanwar YS
    J Clin Invest; 1986 Jan; 77(1):142-56. PubMed ID: 2935558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening.
    Miettinen A; Stow JL; Mentone S; Farquhar MG
    J Exp Med; 1986 May; 163(5):1064-84. PubMed ID: 2939168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis.
    Kashihara N; Makino H; Szekanecz Z; Waltenbaugh CR; Kanwar YS
    Lab Invest; 1992 Dec; 67(6):752-60. PubMed ID: 1460866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis.
    Kim HJ; Hong YH; Kim YJ; Kim HS; Park JW; Do JY; Kim KJ; Bae SW; Kim CW; Lee CK
    Lupus; 2017 Jul; 26(8):815-824. PubMed ID: 28420046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of immune complexes with glomerular heparan sulfate-proteoglycans.
    Kanwar YS; Caulin-Glaser T; Gallo GR; Lamm ME
    Kidney Int; 1986 Dec; 30(6):842-51. PubMed ID: 2950267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular injury induced by antibodies against heparan sulfate proteoglycan (HSPG) derived from PYS 2 cells.
    Yoshida F; Matsuo S; Hiramatsu T; Okura T; Yuzawa Y; Watanabe Y; Sakamoto N; Matsuo S
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):135-43. PubMed ID: 2525633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered glomerular localization of heparan sulfate proteoglycan in experimental nephritides.
    Uchida M; Shibata N; Katoh M; Shigematsu H
    Acta Pathol Jpn; 1986 Jun; 36(6):827-38. PubMed ID: 2945356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of glomerular proteoglycans in aminonucleoside nephrosis.
    Lelongt B; Makino H; Kanwar YS
    Kidney Int; 1987 Jun; 31(6):1299-310. PubMed ID: 2441105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins.
    Jalkanen M; Rapraeger A; Bernfield M
    J Cell Biol; 1988 Mar; 106(3):953-62. PubMed ID: 2964452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive passive Heymann nephritis in the rat.
    Barabas AZ; Boyd N; Cornish J; Lannigan R
    Lab Invest; 1982 Oct; 47(4):400-5. PubMed ID: 6214666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal localization of heparan sulfate proteoglycan by immunohistochemistry.
    Klein DJ; Oegema TR; Eisenstein R; Furcht L; Michael AF; Brown DM
    Am J Pathol; 1983 Jun; 111(3):323-30. PubMed ID: 6222657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
    Klein DJ; Brown DM; Oegema TR
    Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular basement membrane proteoglycans are derived from a large precursor.
    Klein DJ; Brown DM; Oegema TR; Brenchley PE; Anderson JC; Dickinson MA; Horigan EA; Hassell JR
    J Cell Biol; 1988 Mar; 106(3):963-70. PubMed ID: 2964453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen.
    Oite T; Batsford SR; Mihatsch MJ; Takamiya H; Vogt A
    J Exp Med; 1982 Feb; 155(2):460-74. PubMed ID: 6460074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo turnover of the basement membrane and other heparan sulfate proteoglycans of rat glomerulus.
    Beavan LA; Davies M; Couchman JR; Williams MA; Mason RM
    Arch Biochem Biophys; 1989 Mar; 269(2):576-85. PubMed ID: 2521995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
    Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of renal injury initiated by immunization of rats with heparan sulfate.
    Abrass CK; Cohen AH
    Am J Pathol; 1988 Jan; 130(1):103-11. PubMed ID: 2962503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basement membrane heparan sulfate proteoglycan from the L2 rat yolk sac carcinoma.
    Fenger M; Wewer U; Albrechtsen R
    FEBS Lett; 1984 Jul; 173(1):75-9. PubMed ID: 6235128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.